Hepatocyte Growth Factor (HGF) receptor, encoded by the protooncogene c-met, is overexpressed in many human tumours, including those of thyroid epithelium. The absence in most cases of any primary structural abnormality of the met gene suggests that overexpression is secondary to mutation of other gene(s). To test this hypothesis we investigated the eect on met expression of two activated oncogenes known to play a major role in thyroid oncogenesis, ras and ret. To minimize the possibility of unknown co-operating events, we introduced these genes directly into normal human thyrocytes in primary culture using amphotropic retroviral vectors and assessed met expression as early as possible in the resulting epithelial colonies. Double immuno¯uorescence revealed expression of met protein, strictly localized to cells expressing the mutant ras and ret vectors, expression in background normal cells being barely detectable. In contrast, colonies induced to proliferate at a comparable rate by a vector expressing SV40 T showed no increase in met expression. To permit quantitation by Western blotting we also extended these ®ndings to a thyroid cell line (R18) containing a zincinducible mutant ras gene. Induction of the oncogene led to a fourfold increase in met protein expression. We conclude that overexpression of met is induced by activation of the ras or ret signalling pathway and not simply by deregulation of the cell cycle per se. The data suggest that the proliferative advantage conferred by these oncogenes may be in part due to the resulting sensitization of tumour epithelium to paracrine HGF secreted by stromal cells.
Introduction
The c-met proto-oncogene encodes a transmembrane tyrosine kinase of 190 kDa, identi®ed as the receptor for hepatocyte growth factor (HGF) Naldini et al., 1991) . Although c-met activation was originally associated with rearrangements or gene ampli®cation in some cell lines (Park et al., 1986; Ponzetto et al., 1991) , in primary human tumours this is very rare, abnormalities in expression of c-met being usually found in the apparent absence of any underlying structural gene alteration (Houldsworth et al., 1990; Di Renzo et al., 1991) . Met protein has now been reported to be overexpressed in comparison to the corresponding normal epithelium in a wide range of epithelial tumours, including pancreatic (Di Renzo et al., 1995a) , colorectal (Di Renzo et al., 1991; Liu et al., 1992) , ovarian (Di Renzo et al., 1994) , gastric and renal carcinomas (Di Renzo et al., 1991) . Thyroid is a particularly good example with met protein being overexpressed up to 100-fold in the vast majority of papillary carcinomas, and also in a signi®cant proportion of follicular tumours (Di Renzo et al., 1991 Prat et al., 1991) .
The ligand for the receptor encoded by c-met, HGF, is produced by mesenchymal cells from various organs (Stoker et al., 1987; Rubin et al., 1991; Sonnenberg et al., 1993) and has been shown to be a potent mitogen for a variety of epithelial cells in vitro, including hepatocytes (Strain et al., 1991) , renal tubular cells (Igawa et al., 1991) , melanocytes (Matsumoto et al., 1991a) , keratinocytes (Matsumoto et al., 1991b) , normal and oncogene-transformed thyroid cells (Eccles et al., 1996) . Overexpression of the c-met protein by human epithelium may therefore confer increased sensitivity to HGF produced by surrounding stromal cells, thereby representing a signi®cant paracrine contribution to tumour growth.
The absence in most cases of structural abnormality of the met gene in human tumours suggests that overexpression is secondary to mutation of other genes, an obvious possibility being induction by activation of signal pathways containing an activated oncoprotein. The proportion of cases exhibiting met overexpression among some tumour types greatly exceeds that for any individual oncogene activation event so far identi®ed (Di Renzo et al., 1991 , 1995b Prat et al., 1991) , suggesting that multiple oncogenic signals converge on met.
To test this hypothesis, we have investigated the eect on met expression of activating the two principal oncogenes known to play a major role in early thyroid oncogenesis: ras, which is activated by point mutation in up to 50% of follicular tumours (Lemoine et al., 1989a; Namba et al., 1990; Suarez et al., 1990) and ret, which is activated by rearrangement in at least 25% of papillary tumours (Grieco et al., 1990; Santoro et al., 1992) .
To minimize the possibility of unknown cooperating genetic abnormalities, we ®rst tested the response to mutant ras or ret genes in the context of the normal human thyroid follicular cell. We have previously demonstrated the feasibility of obtaining stable expression of these genes in such cells in primary culture by the use of amphotropic retroviral vectors (Lemoine et al., 1990; Bond et al., 1994) . In both cases expression of the mutant gene induces rapid growth of epithelial colonies which are easily distinguishable from the quiescent normal background monolayer, allowing us to investigate the early eect of oncogene activation on c-met protein expression by immunocytochemistry.
To permit more accurate quantitation by Western analysis we also investigated the expression of met protein in a thyroid cell line (R18) containing a zincinducible mutant ras expression vector which has been shown to have no eect on cell proliferation (Dawson et al., 1995) .
Results
Mutant ret and ras oncogenes induce overexpression of met in human thyroid cells in primary culture
Infection of primary cultures of normal human thyroid follicular cells with retroviral vectors encoding mutant H-ras or ret oncogenes, led as expected (Lemoine et al., 1990; Bond et al., 1994) to the appearance of rapidly growing epithelial colonies which were readily distinguishable from the surrounding uninfected quiescent monolayer by 1 ± 2 weeks. (Normal thyroid cells show very limited proliferative capacity in monolayer (Dawson et al., 1991) ). Many of the ret colonies displayed the distinctive`fenestrated' morphology reported earlier (Bond et al., 1994) .
Expression of the appropriate oncogene in these colonies was con®rmed by immunocytochemistry using antibodies to ret and ras antigen (Figure 1a and d) . Ret is not expressed in normal thyroid cells; in the case of ras, endogenous expression is much lower than that of the vector-encoded mutant (Lemoine et al., 1990; Dawson et al., 1995) .
Expression of met in these two types of colonies was also investigated by immunocytochemistry using a monoclonal antibody against the extracellular domain (DO24) (Prat et al., 1991) . Immunoblot analysis was not performed because we wished to analyse cells as soon as possible after introduction of the mutant oncogene, to minimise selection for additional abnormalities. Furthermore, only a minority of colonies would be expected to generate sucient cell numbers for Western analysis before undergoing senescence (Bond et al., 1994 ). An additional advantage oered by immunocytochemistry here was that in cultures not selected in G418 we were able to directly compare the staining in oncogene-generated colonies with that of the surrounding normal cells (Figure 1b , e and g).
Strong immunostaining with anti-met antibody was observed in a large proportion of ras-and ret-induced colonies (25/36 and 22/30 respectively) analysed 12 days after introduction of the activated oncogene. Within these clones, the majority of cells were positive. By comparison, in surrounding normal cells staining was either very faint or undetectable (Figure 1b, c and e).
The above analyses were necessarily performed on dierent examples of each type of colony. In order to directly con®rm the association between overexpression of c-met/HGF receptor and expression of the activated oncogene, double immuno¯uorescence was used to permit simultaneous analysis of ret and met proteins in appropriate colonies (Figure 2 ). Met was seen to be expressed on the plasma membrane and/or in the cytoplasm of 68% (15 out of 22) colonies positive for ret.
Met overexpression is not correlated with proliferation rate
We next addressed the question of whether the increased expression of met was speci®cally due to oncogene activation or whether it was simply a secondary consequence of the resulting stimulation of cell proliferation.
A set of 14 randomly-selected colonies induced by mutant ras were subjected to simultaneous analysis of met protein expression (by immuno¯uorescence) and DNA synthesis (by nuclear bromodeoxyuridine incorporation). Twelve colonies were positive for met and showed a BrdU labelling index of 57.7%+2.8 (mean+s.e.m.); two were negative for met and had a labelling index of 69.5%+9.5 (means+s.e.m.). Figure  3 illustrates the two extremes of met positivity in a ras colony with low proliferation rate ( Figure 3a) contrasting with met negativity in a rapidly proliferating clone (Figure 3b ). Overall, there was therefore no correlation between the level of met expression and proliferation rate.
We also induced colonies by expression of SV40 large T antigen as reported previously (Lemoine et al., 1989b; Bond et al., 1996 in press). In contrast with ras and ret, 12 SV40 T-induced colonies investigated by immunoperoxidase never showed met immunostaining exceeding that of the surrounding normal cells ( Figure  1g ). Nine colonies were also analysed by simultaneous immuno¯uorescence and bromodeoxyuridine labelling. Again all were met-negative despite a BrdU index (66.3+3.7) similar to that of the met-positive ras clones (57.7%+9.5). An example of an SV40 T colony double labelled for bromodeoxyuridine and met is shown in Figure 3c .
Induction of met by mutant ras in a thyroid cell line (R18)
To provide more quantitative support for our ®ndings in primary cultures, we also used a thyroid epithelial cell line previously developed in our laboratory by infecting an SV40 transformed line with a retroviral vector encoding a mutant H-ras under the control of a metallothionein promoter (Dawson et al., 1995) . The expression of the oncogene in this cell line (R18) is inducible by zinc ions and has been shown to not signi®cantly aect cell proliferation (Dawson et al., 1995) . After 4 days induction with Zn 2+ immunoprecipitation followed by Western analysis showed a fourfold increase in met expression in R18 cells, assessed by densitometry (Figure 4) . Uninduced R18 showed higher expression than the parental HT-ori3 line owing to vector leakiness, as reported previously for this cell line (Dawson et al., 1995) .
Discussion
Investigation of the direct phenotypic consequences of activating a single oncogene is ideally performed in the context of a normal cell derived from the appropriate human tissue, cell lines always being liable to misleading results due to pre-existing, additional genetic abnormalities. Primary epithelial cells have retrovirally-mediated transduction of activated oncogenes (ras or ret) known to be associated with tumour initiation in vivo (Lemoine et al., 1990; Bond et al., 1994) . The resulting colonies represent a good in vitro analogue of the two common types of thyroid tumour ± follicular and papillary ± associated respectively with these two oncogenes and provide an excellent`isogeneic' model for studying the speci®c The results show clearly that met protein expression, as demonstrated by immunoperoxidase or immunouorescence analysis was greatly elevated in the majority of epithelial colonies expressing activated ras or ret oncogenes in comparison to its barely-detectable level in the background normal cells. (The reason for its absence in a minority of colonies is presently unclear.) Met was detected both at the plasma membrane and in the cytoplasm of transformed cells, which is in agreement with the localization described in thyroid tumours in vivo (Prat et al., 1991; . Quantitation of the magnitude of met protein overexpression by Western blot analysis was not practicable using early oncogene-induced colonies due to their limited size. Instead this was achieved using a cell line model (R18) in which the induction of mutant ras expression was shown to lead to a fourfold increase in met protein expression.
Three independent results suggest that met overexpression is not simply a passive consequence of any deregulation of the cell cycle, but is related more speci®cally to`upstream' signals generated by ras, ret (and possibly other) oncogenes. Firstly, undetectable or very low levels of met protein (similar to uninfected quiescent cells) were observed in all SV40 T-induced colonies despite similar proliferation rate to ras/ret colonies. Secondly, in ras colonies, where the labelling index showed considerable clone to clone variability, this was not correlated with the intensity of met staining. Thirdly, in R18 cells met expression was increased by the induction of the ras oncogene without any corresponding eect on cell proliferation.
The mechanism of oncogene-dependent met overexpression has not been addressed here and will form the subject of a future study. Western blot and immunocytochemical studies of clinical thyroid samples have led to the suggestion of a post-transcriptional level of control (Di Renzo et al., 1991) . However, this has not been supported, as far as we are aware, by any direct comparison of mRNA and protein levels between normal and neoplastic thyroid tissue. In other tumour systems, for example colon and pancreas (also noted for their high frequency of ras oncogene activation) met mRNA is clearly increased in the tumors (Liu et al., 1992; Di Renzo et al., 1995a) suggesting a possible transcriptional level of control. Furthermore, met transcription in cell lines has been shown to be stimulatable by serum or TPA (Boccaccio et al., 1994) , which are likely to share some signalling pathways with the activated oncogenes employed here. Analysis of the met promoter region has so far revealed the presence of AP2 sites, which could mediate such signals .
Taken together, our data demonstrate that activated oncogenes can induce met overexpression in thyroid epithelium. Although our experimental model does not reveal any resulting proliferative advantage, this is readily explained by the growth-factor-rich in vitro environment rendering any met-mediated growth signals redundant. In the in vivo tumour situation, however, increased met expression may well confer a signi®cant growth advantage by sensitizing tumour epithelium to HGF derived from adjacent stromal cells, thereby contributing to the proliferogenic action of oncogenes such as ras and ret. It is interesting in this regard that stroma is particularly abundant not only in papillary thyroid but also in pancreatic cancer (Scarpelli, 1994) , which also exhibits high levels of met expression (Di Renzo et al., 1995a) . We have recently demonstrated (Eccles et al., 1996) that HGF can stimulate the growth of ret-induced thyrocyte colonies, giving further support to such a paracrine mechanism.
Materials and methods

Cell cultures
Monolayer primary cultures were prepared from surgical samples of histologically-normal human thyroid tissue, by protease digestion and mechanical disaggregation as described previously . Cultures were maintained in a 2 : 1 : 1 (by volume) mixture of Dulbecco's modi®ed Eagles' medium, Ham's F-12 and MCDB 104 (Bond et al., 1992) , supplemented with 10% fetal calf serum (Imperial Laboratories, London, UK). R18 cells and the parent cell line HT-ori3 were maintained in RPMI medium supplemented with 10% fetal calf serum and Geneticin (G418, Gibco BRL) 400 mg/ml. Ras gene expression was induced in R18 using 100 mM ZnSO 4 for 48 h followed by 50 mM in serum free RPMI containing 0.01% BSA (Dawson et al., 1995) . As controls, R18 and HT-ori3 were grown in similar conditions but in the absence of Zn 2+ .
Retroviral vectors
Monolayer primary cultures were infected with the following defective amphotropic vectors: (i) psi-CRIP-DOEJ coding for the val12 mutant of human H-ras, described previously (Lemoine et al., 1990) ; (ii) psi-CRIP-PTC (Bond et al., 1994) encoding an activated human ret protein from a rearranged cDNA (Santoro et al., 1993) ; (iii) psi-CRIP-SVU19 (Bond et al., in press) expressing the non-origin-binding U19 mutant of SV40 large T (Jat and Sharp, 1986) .
All the vectors also express the neo gene, allowing selection of infected cells using Geneticin, 400 mg/ml. 
Retroviral gene transfer
Primary cultures were plated at 5610 5 cells per 60 mm dish and infected 2 days later with retrovirus-containing medium from near-con¯uent cells containing 8 mg/ml polybrene as described previously (Bond et al., 1994) . Four days later, cells were passaged with or without G418 into single-well`permanox' chamber-slides (Life Technologies Ltd, Paisley, UK).
Immunocytochemistry
Twelve days after infection with vectors encoding ras or ret (24 days for SV40 large T), monolayers were ®xed in methanol : acetone (1 : 1) and analysed by immunocytochemistry using the following primary antibodies diluted as appropriate in PBS/1% BSA:
(i) Y 13-259 rat anti-ras p21 monoclonal antibody (Furth et al., 1982) ; (ii) rabbit polyclonal anti-ret, directed against a C-terminal 20-mer of p57 ret (Ishizaka et al., 1992) (kindly provided by T Ushijima, NCCRI, Tokyo); (iii) mouse monoclonal anti-large T antibody pAb 419 (Harlow et al., 1981) ; (iv) mouse monoclonal anti-met antibody DO24 (Prat et al., 1991) , directed against the extracellular domain of human c-met oncogene product. For immunoperoxidase, a standard indirect procedure was followed, using HRP-conjugated rabbit anti-mouse IgG, swine anti-rabbit IgG or sheep anti-rat IgG (Dako) (1 : 100 dilution) as appropriate. For double immuno¯uorescence, ret was detected by the rabbit polyclonal followed by TRITC-conjugated goat anti-rabbit Ig (Southern Biotech, Alabama); met was detected by mouse monoclonal D024 followed by FITC-conjugated goat anti-mouse IgG (Southern Biotech, Alabama). A pilot study using mouse monoclonal anti-cytokeratin LE61 and rabbit polyclonal anti-thyroglobulin as primary antibodies on human thyroid cells was carried out to check the species-speci®city of the second antibodies. No cross reaction was detected.
A special protocol was used to investigate any potential correlation between met expression and cell proliferation. Brie¯y, colonies were incubated with 10 mM 5-bromo-2'-deoxyuridine (Boehringer) for 24 h followed by 15 min ®xation in 4% formaldehyde. Fixed cells were washed in PBS for 30 min, permeabilized in 0.2% Triton6100 for 15 min,`blocked' in 10% fetal calf serum for 30 min, incubated for 1 h with 1 : 400 dilution of DO24 ascites uid, followed by TRITC-conjugated goat anti mouse IgG (Southern Biotech, Alabama). Finally, FITC-labelled mouse monoclonal antibody to bromodeoxyuridine (Boehringer) was added (following the manufacturer's protocol).
Immunoprecipitation and Western blotting
Cells were lysed in NET buer (150 mM NaCl, 50 mM Tris, 1%NP40, 10 mM aprotinin), centrifuged at 20 000 g for 30 min to remove high molecular weight DNA. Protein concentration in the lysate was measured using a Coomassie Plus Protein Assay kit (Pierce) and 200 mg of protein were used from each sample. 1 ml DO24 ascites uid was added to immunoprecipitate met protein (overnight incubation) followed by extraction with Protein G Sepharose (Pharmacia) for 40 min. Bound proteins were resolved on a 7.5% polyacrylamide gel alongside high molecular weight markers (Biorad) and electroblotted onto a PVDF membrane. This was probed with 1 mg/ml rabbit polyclonal antibody recognising the carboxyterminal region of met protein (C-28, Santa Cruz). Met protein was visualised with an ECL system using HRP-coupled anti rabbit IgG (Amersham).
